Humacyte Inc (HUMA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HUMA Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Humacyte Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent79.90
Cash & Short-term Investments79.00
Accounts receivable0.33
Inventories6.99
Prepaid Expense And Other Assets Current5.57
Total Current Assets92.79
Equipment/Property/Plant Net16.17
Other Assets, Noncurrent29.13
Finance Lease Right Of Use Asset28.70
Total Assets138.09
Liabilities
Accounts Payable, Current AC4.16
Accrued Liabilities, Current AC9.27
Unsecured Debt, Current UN0.00
Other Liabilities, Current1.52
Total Current Liabilities14.95
Long-term debt36.32
Long-term Debt Convertible2.91
Total Long-term Debt39.24
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent52.64
Finance Lease Liability Current2.43
Finance Lease Liability Noncurrent27.60
Total Liabilities106.83
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock812.50
Retained Earnings / Accumulated Deficit-781.27
Defined Benefit Plan and Other15.65
Other Equity0.00
Common Stockholder's Equity31.26
Total Stockholder's Equity31.26
Liabilities & Stockholder's Equity138.09
4 historic quarters locked

Sign in to unlock the full Humacyte Inc balance sheet history.

About Humacyte Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-347022

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.